Over the trailing 12 months, BIVI insiders bought $49,118 worth of shares (23.28K shares) in open-market trades, with no open-market sales.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Terren S Peizer | Director, TenPercentOwner | 0 | 231,662 | 231,662 | 83.3% | 16 Aug, 2022 |
| 2 | Cuong V Do | President Ceo | 16,117 | 6,657 | 22,774 | 8.2% | 28 Aug, 2026 |
| 3 | Joseph M Palumbo | Chief Medical Officer | 6,407 | 0 | 6,407 | 2.3% | 28 Aug, 2026 |
| 4 | Richard J Berman | Director | 4,406 | 0 | 4,406 | 1.6% | 07 Jan, 2025 |
| 5 | Joanne Wendy Kim | Chief Financial Officer | 3,832 | 0 | 3,832 | 1.4% | 28 Aug, 2026 |
| 6 | Sigmund Rogich | Director | 3,693 | 0 | 3,693 | 1.3% | 07 Jan, 2025 |
| 7 | Steve Gorlin | Director | 1,306 | 0 | 1,306 | 0.5% | 05 Dec, 2023 |
| 8 | Robert J Hariri | Director | 765 | 0 | 765 | 0.3% | 05 Dec, 2023 |
| 9 | Amy Suzon Chappell | Director | 727 | 0 | 727 | 0.3% | 28 Aug, 2026 |
| 10 | James Paul Lang | Director | 686 | 0 | 686 | 0.2% | 12 Jan, 2023 |
| 11 | Jonathan M Adams | Evp Liver Cirrhosis Programs | 486 | 0 | 486 | 0.2% | 15 Feb, 2022 |
| 12 | Penelope Markham | Evp Liver Cirrhosis Rd | 478 | 0 | 478 | 0.2% | 22 Feb, 2023 |
| 13 | Clarence N. Ahlem | Evp Neuroscience Product Dev. | 371 | 0 | 371 | 0.1% | 21 Feb, 2023 |
| 14 | Christopher Reading | Evp Neuroscience Rd | 371 | 0 | 371 | 0.1% | 22 Feb, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 27 Aug, 2026 | Cuong V Do | President Ceo | Acquired P | 15,210 | $2.08 | $31.64K | 16,117 | Direct |
| 28 Aug, 2026 | Amy Suzon Chappell | Director | Acquired P | 727 | $2.16 | $1.57K | 727 | Direct |
| 28 Aug, 2026 | Joseph M Palumbo | Chief Medical Officer | Acquired P | 4,843 | $2.16 | $10.46K | 6,036 | Direct |
| 28 Aug, 2026 | Joanne Wendy Kim | Chief Financial Officer | Acquired P | 2,500 | $2.18 | $5.45K | 3,441 | Direct |
| 05 Jan, 2026 | Michael Edward Sherman | Director | Acquired A | 80,000 | $0.00 | $0 | 80,000 | Direct |
| 05 Jan, 2026 | Joseph M Palumbo | Chief Medical Officer | Acquired A | 132,000 | $0.00 | $0 | 132,000 | Direct |
| 05 Jan, 2026 | Cuong V Do | President Ceo | Acquired A | 665,300 | $0.00 | $0 | 665,300 | Indirect |
| 05 Jan, 2026 | Joanne Wendy Kim | Chief Financial Officer | Acquired A | 110,100 | $0.00 | $0 | 110,100 | Direct |
| 05 Jan, 2026 | James Paul Lang | Director | Acquired A | 90,000 | $0.00 | $0 | 90,000 | Direct |
| 05 Jan, 2026 | Kameel D. Farag | Director | Acquired A | 57,500 | $0.00 | $0 | 57,500 | Direct |
| 05 Jan, 2026 | Amy Suzon Chappell | Director | Acquired A | 57,500 | $0.00 | $0 | 57,500 | Direct |
| 05 Jan, 2026 | Sigmund Rogich | Director | Acquired A | 70,000 | $0.00 | $0 | 70,000 | Direct |
| 05 Jan, 2026 | James Paul Lang | Director | Acquired A | 330,500 | $0.00 | $0 | 330,500 | Direct |
| 05 Jan, 2026 | Michael Edward Sherman | Director | Acquired A | 341,100 | $0.00 | $0 | 341,100 | Direct |
| 05 Jan, 2026 | Sigmund Rogich | Director | Acquired A | 141,100 | $0.00 | $0 | 141,100 | Direct |
| 07 Aug, 2025 | Cuong V Do | President Ceo | Acquired P | 5,000 | — | — | 9,992 | Indirect |
| 07 Aug, 2025 | Cuong V Do | President Ceo | Acquired P | 5,000 | — | — | 5,050 | Indirect |
| 20 Nov, 2024 | Michael Edward Sherman | Director | Acquired A | 56,900 | $0.00 | $0 | 5,690 | Direct |
| 20 Nov, 2024 | James Paul Lang | Director | Acquired A | 61,600 | $0.00 | $0 | 6,160 | Direct |
| 20 Nov, 2024 | Richard J Berman | Director | Acquired A | 34,200 | $0.00 | $0 | 4,064 | Direct |